QCM
FOLD

Quantinno Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Quantinno Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$575K Buy
39,781
+4,801
+14% +$68.8K ﹤0.01% 2610
2025
Q4 		$498K Buy
34,980
+5,858
+20% +$57.5K ﹤0.01% 2436
2025
Q3 		$229K Buy
+29,122
New +$207K ﹤0.01% 2665
2025
Q2 		– Sell
-11,717
Closed -$95.6K – 2597
2025
Q1 		$95.6K Buy
+11,717
New +$108K ﹤0.01% 2038

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Quantinno Capital Management's FOLD Position: Q1 2026 in Review

Quantinno Capital Management increased its Amicus Therapeutics (FOLD) stake by 14% in Q1 2026, buying an estimated $68.8K and bringing the position to 39,781 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Quantinno Capital Management first reported a position in FOLD in Q1 2025 and has held it in 4 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Quantinno Capital Management held 39,781 shares of Amicus Therapeutics worth $575K as of Q1 2026.
  • Quantinno Capital Management bought 4,801 Amicus Therapeutics shares in Q1 2026, an estimated $68.8K.
  • Amicus Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2610 holding.
  • Quantinno Capital Management first reported a position in Amicus Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.